PT-141 is a synthetic peptide and melanocortin receptor agonist under investigation for its potential to address sexual dysfunction. PT-141 peptide for research has become an area of interest in the scientific community due to its unique mechanisms. It uniquely influences sexual arousal through central nervous system pathways rather than focusing on vascular mechanisms, distinguishing it from other treatments such as PDE5 inhibitors.
PT-141 has gained approval for the management of generalized hypoactive sexual desire disorder (HSDD) in premenopausal women, demonstrating its clinical relevance. Requires reconstitution before use. Additionally, researchers value PT-141 peptide for research because its effects are not limited to one gender.
What is PT-141?
- PT-141 is a cyclic peptide that enhances sexual desire and response; notably, PT-141 peptide for research is explored for its central action on the nervous system.
- Unlike other medications, PT-141 targets the central nervous system directly to increase libido and improve blood circulation to the genitals of both men and women.
- It stimulates the release of dopamine in your brain, the neurotransmitter that regulates libido and sexual motivation. For scientists seeking innovative compounds, PT-141 peptide for research continues to be of significant interest.
Why it’s Amazing?
- Boosted sex drive: PT-141 directly increase libido levels by stimulating dopamine release, which enhances sexual motivation; many researchers document these changes when using PT-141 peptide for research in the lab.
- Backed by science: Several clinical studies have shown PT-141 to induce erectile response in men and improve levels of sexual desire in women;
- Non-invasive administration: A nasal spray formulation can deliver PT-141 more absorption into brain with less degradation and no pain of injection.
Chemical information:
- Cat. #: QT-2105
- CAS#189691-06-3
- Formula: C50H68N14O10
- Sequence: Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp-Lys(1)-OH
- M.W.: 1025.2 g/mol
Chemical Structure:






